United States - English - NLM (National Library of Medicine)

onko pharmaceuticals usa inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

United States - English - NLM (National Library of Medicine)

onko pharmaceuticals usa inc. - alcohol 60% v/v., isopropyl alcohol 10 % v/v. - antiseptic - for sanitizing skin. - suitable for hygienic personal care and disinfectant cleansing within private spaces. - for preparation of the skin prior to injection or venipuncture.

United States - English - NLM (National Library of Medicine)

onko pharmaceuticals usa inc - alcohol 80% - antiseptic. · helps reduce bacteria that potentially can cause disease. · for use when soap and water are not available.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treament of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treatment of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treament of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult actue non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treatment of *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Malta - English - Medicines Authority

onkovis gmbh grube 45, 82377 penzberg , germany - azacitidine - powder for suspension for injection - azacitidine 25 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

onkovis gmbh grube 45, 82377 penzberg , germany - azacitidine - powder for suspension for injection - azacitidine 25 mg/ml - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride -